FDA Approves Fourth Immune Checkpoint Inhibitor for Bladder Cancer
This time last year there were no immune checkpoint inhibitors approved by the U.S. Food and Drug Administration (FDA)...
Category: In the News
This time last year there were no immune checkpoint inhibitors approved by the U.S. Food and Drug Administration (FDA)...
Last week, a flurry of U.S. Food and Drug Administration (FDA) oncology approvals concluded with the approval of the...
At the end of last week, the U.S. Food and Drug Administration (FDA) announced the approval of the first...
Members of the AACR Project GENIE consortium presented their first analyses of the data during the Pan-Cancer Genomic Analysis...
The U.S. Preventive Services Task Force (USPSTF) released draft recommendations April 11 suggesting that doctors inform men ages 55...
On March 23, the U.S. Food and Drug Administration announced the first-ever approval of a treatment for patients with...
Finding a way to therapeutically target the so-called “undruggable” cancer proteins has long been a holy grail of researchers...
The Affordable Care Act, which was enacted in 2010 and recently survived an effort to dismantle it, was the...
Identifying ways to increase the proportion of patients with melanoma who have clinically meaningful and durable responses to immune...
Former Vice President Joe Biden returned to the stage at the American Association for Cancer Research (AACR) Annual Meeting...